Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 26% ± 5% | |
glutamatergic neuron | 3 studies | 31% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1074.73 | 1443 / 1445 | 100% | 12.51 | 183 / 183 |
lung | 100% | 1598.63 | 576 / 578 | 100% | 9.42 | 1151 / 1155 |
breast | 100% | 1894.51 | 459 / 459 | 99% | 11.39 | 1110 / 1118 |
ovary | 100% | 2238.33 | 180 / 180 | 99% | 6.57 | 425 / 430 |
prostate | 100% | 1528.99 | 245 / 245 | 99% | 9.48 | 496 / 502 |
uterus | 100% | 1540.54 | 170 / 170 | 98% | 9.18 | 451 / 459 |
intestine | 100% | 1229.00 | 965 / 966 | 98% | 7.92 | 518 / 527 |
thymus | 100% | 1718.13 | 652 / 653 | 98% | 7.81 | 593 / 605 |
brain | 98% | 843.54 | 2582 / 2642 | 100% | 10.62 | 703 / 705 |
stomach | 99% | 1096.50 | 356 / 359 | 98% | 9.07 | 281 / 286 |
bladder | 100% | 1061.67 | 21 / 21 | 97% | 7.33 | 489 / 504 |
adrenal gland | 100% | 2951.44 | 258 / 258 | 96% | 8.26 | 220 / 230 |
kidney | 100% | 1004.71 | 89 / 89 | 95% | 9.22 | 857 / 901 |
pancreas | 96% | 707.23 | 315 / 328 | 99% | 7.42 | 176 / 178 |
skin | 100% | 2073.76 | 1808 / 1809 | 92% | 8.06 | 434 / 472 |
liver | 100% | 1914.71 | 226 / 226 | 82% | 4.24 | 332 / 406 |
adipose | 100% | 2054.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 932.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.02 | 45 / 45 |
blood vessel | 100% | 1971.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 91% | 809.81 | 781 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 4.53 | 24 / 29 |
muscle | 78% | 411.06 | 624 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 65% | 3.27 | 52 / 80 |
peripheral blood | 61% | 908.98 | 569 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0031208 | Molecular function | POZ domain binding |
GO_0008327 | Molecular function | methyl-CpG binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZBTB21 |
Protein name | Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295) Zinc finger and BTB domain containing 21 (Zinc finger protein 295 variant 1) (Zinc finger protein 295 variant 3) (Zinc finger protein 295 variant 4) Zinc finger and BTB domain containing 21 |
Synonyms | KIAA1227 ZNF295 |
Description | FUNCTION: Acts as a transcription repressor. . |
Accessions | ENST00000425521.1 ENST00000310826.10 [Q9ULJ3-1] Q5KS07 ENST00000398511.3 [Q9ULJ3-1] ENST00000398497.2 Q9ULJ3 E7EVF9 ENST00000398505.7 [Q9ULJ3-2] ENST00000449949.5 ENST00000398499.5 [Q9ULJ3-1] |